Covered recipient · General Payments record
AENA PATEL
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$1,320.89
- Reported across 40 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $225.69 | 9 |
| Education | $16.40 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARRAY BIOPHARMA INC | $52.05 | 2 |
| GENZYME CORPORATION | $49.67 | 2 |
| Regeneron Healthcare Solutions, Inc. | $31.00 | 1 |
| Dendreon Pharmaceuticals LLC | $30.91 | 1 |
| Gilead Sciences, Inc. | $22.33 | 1 |
| Tempus AI, Inc | $20.33 | 1 |
| Exelixis Inc. | $19.40 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC | $27.75 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229313891 | CMS |
| ARRAY BIOPHARMA INC | $24.30 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230834300 | CMS |
| Dendreon Pharmaceuticals LLC | $30.91 | 12/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245008056 | CMS |
| Exelixis Inc. | $19.40 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218790067 | CMS |
| GENZYME CORPORATION | $27.10 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233196842 | CMS |
| GENZYME CORPORATION | $22.57 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233196878 | CMS |
| Gilead Sciences, Inc. | $22.33 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234501553 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.00 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1213007816 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.40 | 02/06/2025 | Education | Undisputed | 06/30/2026 | 1224102442 | CMS |
| Tempus AI, Inc | $20.33 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250349924 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.